Enhancing regenerative medicine:
the crucial role of stem cell
therapy
Jipeng Wang , Gang Deng , Shuyi Wang , Shuang Li , Peng Song , Kun Lin , Xiaoxiang Xu and Zuhong He
- PUBLISHED 08 February 2024
Abstract
Stem cells offer new therapeutic avenues for the repair and replacement of damaged tissues and organs owing to their self-renewal and multipotent differentiation capabilities. In this paper, we conduct a systematic review of the characteristics of various types of stem cells and offer insights into their potential applications in both cellular and cell-free therapies. In addition, we provide a comprehensive summary of the technical routes of stem cell therapy and discuss in detail current challenges, including safety issues and differentiation control. Although some issues remain, stem cell therapy demonstrates excellent potential in the field of regenerative medicine and provides novel tactics and methodologies for managing a wider spectrum of illnesses and traumas.
KEYWORDS
stem cell therapy, secretome, regenerative medicine, mesenchymal stromal cell, regeneration
article original link: click here
References
Aiuti, A., Biasco, L., Scaramuzza, S., Ferrua, F., Cicalese, M. P., Baricordi, C., et al. (2013). Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 341:1233151. doi: 10.1126/science.1233151
Al Madhoun, A., Ali, H., AlKandari, S., Atizado, V. L., Akhter, N., Al-Mulla, F., et al. (2016). Defined three-dimensional culture conditions mediate efficient induction of definitive endoderm lineage from human umbilical cord Wharton’s jelly mesenchymal stem cells. Stem Cell Res Ther 7:165. doi: 10.1186/s13287-016-0426-9
Alvarez, Y., Alonso, M. T., Vendrell, V., Zelarayan, L. C., Chamero, P., Theil, T., et al. (2003). Requirements for FGF3 and FGF10 during inner ear formation. Development 130, 6329–6338. doi: 10.1242/dev.00881
Andrews, P. W., Barbaric, I., Benvenisty, N., Draper, J. S., Ludwig, T., Merkle, F. T., et al. (2022). The consequences of recurrent genetic and epigenetic variants in human pluripotent stem cells. Cell Stem Cell 29, 1624–1636. doi: 10.1016/j.stem.2022.11.006
Asgari Taei, A., Nasoohi, S., Hassanzadeh, G., Kadivar, M., Dargahi, L., and Farahmandfar, M. (2021). Enhancement of angiogenesis and neurogenesis by intracerebroventricular injection of secretome from human embryonic stem cell-derived mesenchymal stem cells in ischemic stroke model. Biomed. Pharmacother. 140:111709. doi: 10.1016/j.biopha.2021.111709
Azizi, F., Jalil, H., Nasiri, Z., Moshtaghian, J., Esmaeili, F., Doostmohammadi, A., et al. (2018). The combined effects of three-dimensional cell culture and natural tissue extract on neural differentiation of P19 embryonal carcinoma stem cells. J. Tissue Eng. Regen. Med. 12, 1909–1924. doi: 10.1002/term.2712
Bacakova, L., Zarubova, J., Travnickova, M., Musilkova, J., Pajorova, J., Slepicka, P., et al. (2018). Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells – a review. Biotechnol. Adv. 36, 1111–1126. doi: 10.1016/j.biotechadv.2018.03.011
Bae, J., Liu, L., Moore, C., Hsu, E., Zhang, A., Ren, Z., et al. (2022). IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8(+) T cells to overcome immunotherapy resistance in cancer. Nat. Cell Biol. 24, 1754–1765. doi: 10.1038/s41556-022-01024-5
Bakir, N. H., Finnan, M. J., MacGregor, R. M., Schilling, J. D., Ewald, G. A., Kotkar, K. D., et al. (2022). Cardiac allograft rejection in the current era of continuous flow left ventricular assist devices. J. Thorac. Cardiovasc. Surg. 163, 124–134.e8. doi: 10.1016/j.jtcvs.2020.06.142
Barker, N., Bartfeld, S., and Clevers, H. (2010). Tissue-resident adult stem cell populations of rapidly self-renewing organs. Cell Stem Cell 7, 656–670. doi: 10.1016/j.stem.2010.11.016
Barrachina, L., Remacha, A. R., Romero, A., Vázquez, F. J., Albareda, J., Prades, M., et al. (2017). Priming equine bone marrow-derived mesenchymal stem cells with Proinflammatory cytokines: implications in immunomodulation-immunogenicity balance, cell viability, and differentiation potential. Stem Cells Dev. 26, 15–24. doi: 10.1089/scd.2016.0209
Bartunek, J., Behfar, A., Dolatabadi, D., Vanderheyden, M., Ostojic, M., Dens, J., et al. (2013). Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J. Am. Coll. Cardiol. 61, 2329–2338. doi: 10.1016/j.jacc.2013.02.071
Baumann, K. (2017). Stem cells: a key to totipotency. Nat. Rev. Mol. Cell Biol. 18:137. doi: 10.1038/nrm.2017.9
Berisha, B., Ragnarsson, S., Olaison, L., and Rasmussen, M. (2022). Microbiological etiology in prosthetic valve endocarditis: a nationwide registry study. J. Intern. Med. 292, 428–437. doi: 10.1111/joim.13491
Bordignon, C. (2006). Stem-cell therapies for blood diseases. Nature 441, 1100–1102. doi: 10.1038/nature04962
Boyle, A. J., Schulman, S. P., Hare, J. M., and Oettgen, P. (2006). Is stem cell therapy ready for patients? Stem cell therapy for cardiac repair. Ready for the next step. Circulation 114, 339–352. doi: 10.1161/CIRCULATIONAHA.105.590653
Carlson, M. L. (2020). Cochlear implantation in adults. N. Engl. J. Med. 382, 1531–1542. doi: 10.1056/NEJMra1904407
Chandy, M., Obal, D., and Wu, J. C. (2022). Elucidating effects of environmental exposure using human-induced pluripotent stem cell disease modeling. EMBO Mol. Med. 14:e13260. doi: 10.15252/emmm.202013260
Charrier, M., Lorant, J., Contreras-Lopez, R., Téjédor, G., Blanquart, C., Lieubeau, B., et al. (2022). Human MuStem cells repress T-cell proliferation and cytotoxicity through both paracrine and contact-dependent pathways. Stem Cell Res Ther 13:7. doi: 10.1186/s13287-021-02681-3
Chen, Y. M., Chen, L. H., Li, M. P., Li, H. F., Higuchi, A., Kumar, S. S., et al. (2017). Xeno-free culture of human pluripotent stem cells on oligopeptide-grafted hydrogels with various molecular designs. Sci. Rep. 7:45146. doi: 10.1038/srep45146
Chen, W., Jongkamonwiwat, N., Abbas, L., Eshtan, S. J., Johnson, S. L., Kuhn, S., et al. (2012). Restoration of auditory evoked responses by human ES-cell-derived otic progenitors. Nature 490, 278–282. doi: 10.1038/nature11415
Chen, R., Li, L., Feng, L., Luo, Y., Xu, M., Leong, K. W., et al. (2020). Biomaterial-assisted scalable cell production for cell therapy. Biomaterials 230:119627. doi: 10.1016/j.biomaterials.2019.119627
Chen, W., Sun, Y., Gu, X., Cai, J., Liu, X., Zhang, X., et al. (2021). Conditioned medium of human bone marrow-derived stem cells promotes tendon-bone healing of the rotator cuff in a rat model. Biomaterials 271:120714. doi: 10.1016/j.biomaterials.2021.120714
Chen, T., Xia, Y., Zhang, L., Xu, T., Yi, Y., Chen, J., et al. (2023). Loading neural stem cells on hydrogel scaffold improves cell retention rate and promotes functional recovery in traumatic brain injury. Mater Today Bio. 19:100606. doi: 10.1016/j.mtbio.2023.100606
Cho, S., Discher, D. E., Leong, K. W., Vunjak-Novakovic, G., and Wu, J. C. (2022). Challenges and opportunities for the next generation of cardiovascular tissue engineering. Nat. Methods 19, 1064–1071. doi: 10.1038/s41592-022-01591-3
Crespo-Leiro, M. G., Costanzo, M. R., Gustafsson, F., Khush, K. K., Macdonald, P. S., Potena, L., et al. (2022). Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies. Eur. Heart J. 43, 2237–2246. doi: 10.1093/eurheartj/ehac204
Czajkowski, A., Mounier, A., Delacroix, L., and Malgrange, B. (2019). Pluripotent stem cell-derived cochlear cells: a challenge in constant progress. Cell. Mol. Life Sci. 76, 627–635. doi: 10.1007/s00018-018-2950-5
Daneshmandi, L., Shah, S., Jafari, T., Bhattacharjee, M., Momah, D., Saveh-Shemshaki, N., et al. (2020). Emergence of the stem cell Secretome in regenerative engineering. Trends Biotechnol. 38, 1373–1384. doi: 10.1016/j.tibtech.2020.04.013
Dreyfus, J., Dreyfus, G. D., and Taramasso, M. (2022). Tricuspid valve replacement: the old and the new. Prog. Cardiovasc. Dis. 72, 102–113. doi: 10.1016/j.pcad.2022.06.004
Duan, J. L., Ruan, B., Song, P., Fang, Z. Q., Yue, Z. S., Liu, J. J., et al. (2022). Shear stress-induced cellular senescence blunts liver regeneration through notch-sirtuin 1-P21/P16 axis. Hepatology 75, 584–599. doi: 10.1002/hep.32209
Duran Alonso, M. B., Lopez Hernandez, I., de la Fuente, M. A., Garcia-Sancho, J., Giraldez, F., and Schimmang, T. (2018). Transcription factor induced conversion of human fibroblasts towards the hair cell lineage. PLoS One 13:e0200210. doi: 10.1371/journal.pone.0200210
Eaves, C. J. (2015). Hematopoietic stem cells: concepts, definitions, and the new reality. Blood 125, 2605–2613. doi: 10.1182/blood-2014-12-570200
Eschenhagen, T., Bolli, R., Braun, T., Field, L. J., Fleischmann, B. K., Frisén, J., et al. (2017). Cardiomyocyte regeneration: a consensus statement. Circulation 136, 680–686. doi: 10.1161/CIRCULATIONAHA.117.029343
Estrada, R., Li, N., Sarojini, H., An, J., Lee, M. J., and Wang, E. (2009). Secretome from mesenchymal stem cells induces angiogenesis via Cyr61. J. Cell. Physiol. 219, 563–571. doi: 10.1002/jcp.21701
Fan, S., Gao, Y., Qu, A., Jiang, Y., Li, H., Xie, G., et al. (2022). YAP-TEAD mediates PPAR α-induced hepatomegaly and liver regeneration in mice. Hepatology 75, 74–88. doi: 10.1002/hep.32105
Fares, J., Ahmed, A. U., Ulasov, I. V., Sonabend, A. M., Miska, J., Lee-Chang, C., et al. (2021). Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial. Lancet Oncol. 22, 1103–1114. doi: 10.1016/S1470-2045(21)00245-X
Fumagalli, F., Calbi, V., Natali Sora, M. G., Sessa, M., Baldoli, C., Rancoita, P. M. V., et al. (2022). Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access. Lancet 399, 372–383. doi: 10.1016/S0140-6736(21)02017-1
Gallina, C., Capelôa, T., Saviozzi, S., Accomasso, L., Catalano, F., Tullio, F., et al. (2015). Human mesenchymal stem cells labelled with dye-loaded amorphous silica nanoparticles: long-term biosafety, stemness preservation and traceability in the beating heart. J Nanobiotechnol. 13:77. doi: 10.1186/s12951-015-0141-1
Gao, P., Ding, Q., Wu, Z., Jiang, H., and Fang, Z. (2010). Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma. Cancer Lett. 290, 157–166. doi: 10.1016/j.canlet.2009.08.031
Gholamigeravand, B., Shahidi, S., Afshar, S., Gholipour, P., Samzadeh-kermani, A., Amiri, K., et al. (2021). Synergistic effects of adipose-derived mesenchymal stem cells and selenium nanoparticles on streptozotocin-induced memory impairment in the rat. Life Sci. 272:119246. doi: 10.1016/j.lfs.2021.119246
Gong, M., Yan, F., Yu, L., and Li, F. (2022). A dopamine-methacrylated hyaluronic acid hydrogel as an effective carrier for stem cells in skin regeneration therapy. Cell Death Dis. 13:738. doi: 10.1038/s41419-022-05060-9
Gupta, A., and Singh, S. (2022). Potential role of growth factors controlled release in achieving enhanced neuronal trans-differentiation from mesenchymal stem cells for neural tissue repair and regeneration. Mol. Neurobiol. 59, 983–1001. doi: 10.1007/s12035-021-02646-w
Gur-Cohen, S., Yang, H., Baksh, S. C., Miao, Y., Levorse, J., Kataru, R. P., et al. (2019). Stem cell-driven lymphatic remodeling coordinates tissue regeneration. Science 366, 1218–1225. doi: 10.1126/science.aay4509
Han, Y., Yang, J., Fang, J., Zhou, Y., Candi, E., Wang, J., et al. (2022). The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Signal Transduct. Target. Ther. 7:92. doi: 10.1038/s41392-022-00932-0
Hofferberth, S. C., Saeed, M. Y., Tomholt, L., Fernandes, M. C., Payne, C. J., Price, K., et al. (2020). A geometrically adaptable heart valve replacement. Sci. Transl. Med. 12:eaay4006. doi: 10.1126/scitranslmed.aay4006
Hu, Y. L., Fu, Y. H., Tabata, Y., and Gao, J. Q. (2010). Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy. J. Control. Release 147, 154–162. doi: 10.1016/j.jconrel.2010.05.015
Hu, Y., Yang, Y., Tan, P., Zhang, Y., Han, M., Yu, J., et al. (2023). Induction of mouse totipotent stem cells by a defined chemical cocktail. Nature 617, 792–797. doi: 10.1038/s41586-022-04967-9
Hu, X., Zhang, L., Jin, J., Zhu, W., Xu, Y., Wu, Y., et al. (2015). Heparanase released from mesenchymal stem cells activates integrin beta1/HIF-2alpha/Flk-1 signaling and promotes endothelial cell migration and angiogenesis. Stem Cells 33, 1850–1862. doi: 10.1002/stem.1995
Hurst, T. P., and Magiorkinis, G. (2017). Epigenetic control of human endogenous retrovirus expression: focus on regulation of long-terminal repeats (LTRs). Viruses 9:130. doi: 10.3390/v9060130
Jian, W. H., Wang, H. C., Kuan, C. H., Chen, M. H., Wu, H. C., Sun, J. S., et al. (2018). Glycosaminoglycan-based hybrid hydrogel encapsulated with polyelectrolyte complex nanoparticles for endogenous stem cell regulation in central nervous system regeneration. Biomaterials 174, 17–30. doi: 10.1016/j.biomaterials.2018.05.009
Jin, J. (2017). Stem cell treatments. JAMA 317:330. doi: 10.1001/jama.2016.17822
Kawada-Horitani, E., Kita, S., Okita, T., Nakamura, Y., Nishida, H., Honma, Y., et al. (2022). Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade. Diabetologia 65, 1185–1197. doi: 10.1007/s00125-022-05708-3
Ke, X., Li, M., Wang, X., Liang, J., Wang, X., Wu, S., et al. (2020). An injectable chitosan/dextran/β-glycerophosphate hydrogel as cell delivery carrier for therapy of myocardial infarction. Carbohydr. Polym. 229:115516. doi: 10.1016/j.carbpol.2019.115516
Kim, H. D., Lee, E. A., Choi, Y. H., An, Y. H., Koh, R. H., Kim, S. L., et al. (2016). High throughput approaches for controlled stem cell differentiation. Acta Biomater. 34, 21–29. doi: 10.1016/j.actbio.2016.02.022
King, N. M., and Perrin, J. (2014). Ethical issues in stem cell research and therapy. Stem Cell Res Ther 5:85. doi: 10.1186/scrt474
Ko, B. S., Drakos, S., Kfoury, A. G., Hurst, D., Stoddard, G. J., Willis, C. A., et al. (2016). Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant. J. Heart Lung Transplant. 35, 1024–1030. doi: 10.1016/j.healun.2016.05.001
Konala, V. B., Mamidi, M. K., Bhonde, R., Das, A. K., Pochampally, R., and Pal, R. (2016). The current landscape of the mesenchymal stromal cell secretome: a new paradigm for cell-free regeneration. Cytotherapy 18, 13–24. doi: 10.1016/j.jcyt.2015.10.008
Praveen Kumar, L., Kandoi, S., Misra, R., Vijayalakshmi, S., and Verma, R. S. (2019). The mesenchymal stem cell secretome: a new paradigm towards cell-free therapeutic mode in regenerative medicine. Cytokine Growth Factor Rev. 46, 1–9. doi: 10.1016/j.cytogfr.2019.04.002
Lenarz, T. (2017). Cochlear implant – state of the art. GMS Curr Top Otorhinolaryngol Head Neck Surg 16:Doc04. doi: 10.3205/cto000143
Li, H., Roblin, G., Liu, H., and Heller, S. (2003). Generation of hair cells by stepwise differentiation of embryonic stem cells. Proc. Natl. Acad. Sci. USA 100, 13495–13500. doi: 10.1073/pnas.2334503100
Li, M., Sun, S., Dangelmajer, S., Zhang, Q., Wang, J., Hu, F., et al. (2019). Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma. Stem Cell Res Ther 10:88. doi: 10.1186/s13287-019-1194-0
Li, Z., Yan, G., Diao, Q., Yu, F., Li, X., Sheng, X., et al. (2019). Transplantation of human endometrial perivascular cells with elevated CYR61 expression induces angiogenesis and promotes repair of a full-thickness uterine injury in rat. Stem Cell Res Ther 10:179. doi: 10.1186/s13287-019-1272-3
Lilja, A. M., Rodilla, V., Huyghe, M., Hannezo, E., Landragin, C., Renaud, O., et al. (2018). Clonal analysis of Notch1-expressing cells reveals the existence of unipotent stem cells that retain long-term plasticity in the embryonic mammary gland. Nat. Cell Biol. 20, 677–687. doi: 10.1038/s41556-018-0108-1
Lin, M. J., and Lu, C. P. (2021). Glandular stem cells in the skin during development, homeostasis, wound repair and regeneration. Exp. Dermatol. 30, 598–604. doi: 10.1111/exd.14319
Liu, Y., Graves, D. T., and Wang, S. (2023). Development and clinical application of human mesenchymal stem cell drugs. Sci Bull (Beijing). 68, 860–863. doi: 10.1016/j.scib.2023.03.050
Liu, Z., Mikrani, R., Zubair, H. M., Taleb, A., Naveed, M., Baig, M. M. F. A., et al. (2020). Systemic and local delivery of mesenchymal stem cells for heart renovation: challenges and innovations. Eur. J. Pharmacol. 876:173049. doi: 10.1016/j.ejphar.2020.173049
Lv, M., Zhang, S., Jiang, B., Cao, S., Dong, Y., Cao, L., et al. (2021). Adipose-derived stem cells regulate metabolic homeostasis and delay aging by promoting mitophagy. FASEB J. 35:e21709. doi: 10.1096/fj.202100332R
Ma, S., Xie, N., Li, W., Yuan, B., Shi, Y., and Wang, Y. (2014). Immunobiology of mesenchymal stem cells. Cell Death Differ. 21, 216–225. doi: 10.1038/cdd.2013.158
MacGregor-Ramiasa, M., Hopp, I., Bachhuka, A., Murray, P., and Vasilev, K. (2017). Surface nanotopography guides kidney-derived stem cell differentiation into podocytes. Acta Biomater. 56, 171–180. doi: 10.1016/j.actbio.2017.02.036
Maj, M., Kokocha, A., Bajek, A., and Drewa, T. (2018). The interplay between adipose-derived stem cells and bladder cancer cells. Sci. Rep. 8:15118. doi: 10.1038/s41598-018-33397-9
Malik, V., and Wang, J. (2022). Pursuing totipotency: authentic totipotent stem cells in culture. Trends Genet. 38, 632–636. doi: 10.1016/j.tig.2022.03.012
Mardpour, S., Ghanian, M. H., Sadeghi-Abandansari, H., Mardpour, S., Nazari, A., Shekari, F., et al. (2019). Hydrogel-mediated sustained systemic delivery of mesenchymal stem cell-derived extracellular vesicles improves hepatic regeneration in chronic liver failure. ACS Appl. Mater. Interfaces 11, 37421–37433. doi: 10.1021/acsami.9b10126
Melton, D. (2021). The promise of stem cell-derived islet replacement therapy. Diabetologia 64, 1030–1036. doi: 10.1007/s00125-020-05367-2
Michalopoulos, G. K., and Bhushan, B. (2021). Liver regeneration: biological and pathological mechanisms and implications. Nat. Rev. Gastroenterol. Hepatol. 18, 40–55. doi: 10.1038/s41575-020-0342-4
Mierzejewski, B., Archacka, K., Grabowska, I., Florkowska, A., Ciemerych, M. A., and Brzoska, E. (2020). Human and mouse skeletal muscle stem and progenitor cells in health and disease. Semin. Cell Dev. Biol. 104, 93–104. doi: 10.1016/j.semcdb.2020.01.004
Morgan, R. A., Gray, D., Lomova, A., and Kohn, D. B. (2017). Hematopoietic stem cell gene therapy: Progress and lessons learned. Cell Stem Cell 21, 574–590. doi: 10.1016/j.stem.2017.10.010
Mousaei Ghasroldasht, M., Seok, J., Park, H. S., Liakath Ali, F. B., and Al-Hendy, A. (2022). Stem cell therapy: from idea to clinical practice. Int. J. Mol. Sci. 23:2850. doi: 10.3390/ijms23052850
Mummery, C. L., Zhang, J., Ng, E. S., Elliott, D. A., Elefanty, A. G., and Kamp, T. J. (2012). Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ. Res. 111, 344–358. doi: 10.1161/CIRCRESAHA.110.227512
Nayagam, B. A., Backhouse, S. S., Cimenkaya, C., and Shepherd, R. K. (2012). Hydrogel limits stem cell dispersal in the deaf cochlea: implications for cochlear implants. J. Neural Eng. 9:065001. doi: 10.1088/1741-2560/9/6/065001
Ng, A., Khoshakhlagh, P., Rojo Arias, J. E., Pasquini, G., Wang, K., Swiersy, A., et al. (2021). A comprehensive library of human transcription factors for cell fate engineering. Nat. Biotechnol. 39, 510–519. doi: 10.1038/s41587-020-0742-6
Niu, H., Li, X., Li, H., Fan, Z., Ma, J., and Guan, J. (2019). Thermosensitive, fast gelling, photoluminescent, highly flexible, and degradable hydrogels for stem cell delivery. Acta Biomater. 83, 96–108. doi: 10.1016/j.actbio.2018.10.038
Noiseux, N., Gnecchi, M., Lopez-Ilasaca, M., Zhang, L., Solomon, S. D., Deb, A., et al. (2006). Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol. Ther. 14, 840–850. doi: 10.1016/j.ymthe.2006.05.016
Nourian Dehkordi, A., Mirahmadi Babaheydari, F., Chehelgerdi, M., and Raeisi, D. S. (2019). Skin tissue engineering: wound healing based on stem-cell-based therapeutic strategies. Stem Cell Res Ther 10:111. doi: 10.1186/s13287-019-1212-2
Oraee-Yazdani, S., Tavanaei, R., Rostami, F., Hajarizadeh, A., Mehrabadi, M., Akhlaghpasand, M., et al. (2023). Suicide gene therapy using allogeneic adipose tissue-derived mesenchymal stem cell gene delivery vehicles in recurrent glioblastoma multiforme: a first-in-human, dose-escalation, phase I clinical trial. J. Transl. Med. 21:350. doi: 10.1186/s12967-023-04213-4
Oshima, K., Shin, K., Diensthuber, M., Peng, A. W., Ricci, A. J., and Heller, S. (2010). Mechanosensitive hair cell-like cells from embryonic and induced pluripotent stem cells. Cell 141, 704–716. doi: 10.1016/j.cell.2010.03.035
Ouyang, X., Wang, X., Kraatz, H. B., Ahmadi, S., Gao, J., Lv, Y., et al. (2020). A Trojan horse biomimetic delivery strategy using mesenchymal stem cells for PDT/PTT therapy against lung melanoma metastasis. Biomater. Sci. 8, 1160–1170. doi: 10.1039/C9BM01401B
Pakravan, K., Babashah, S., Sadeghizadeh, M., Mowla, S. J., Mossahebi-Mohammadi, M., Ataei, F., et al. (2017). MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells. Cell. Oncol. (Dordr) 40, 457–470. doi: 10.1007/s13402-017-0335-7
Panés, J., García-Olmo, D., Van Assche, G., Colombel, J. F., Reinisch, W., Baumgart, D. C., et al. (2018). Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn’s disease. Gastroenterology 154, 1334–1342.e4. doi: 10.1053/j.gastro.2017.12.020
Park, Y. S., Hwang, S., Jin, Y. M., Yu, Y., Jung, S. A., Jung, S. C., et al. (2015). CCN1 secreted by tonsil-derived mesenchymal stem cells promotes endothelial cell angiogenesis via integrin αv β3 and AMPK. J. Cell. Physiol. 230, 140–149. doi: 10.1002/jcp.24690
Pessina, A., Coccè, V., Pascucci, L., Bonomi, A., Cavicchini, L., Sisto, F., et al. (2013). Mesenchymal stromal cells primed with paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice. Br. J. Haematol. 160, 766–778. doi: 10.1111/bjh.12196
Pierson Smela, M. D., Kramme, C. C., Fortuna, P., Adams, J. L., Su, R., Dong, E., et al. (2023). Directed differentiation of human iPSCs to functional ovarian granulosa-like cells via transcription factor overexpression. elife 12:e83291. doi: 10.7554/eLife.83291
Prentice, D. A. (2019). Adult Stem Cells. Circ. Res. 124, 837–839. doi: 10.1161/CIRCRESAHA.118.313664
